One-Year Outcomes of OCT-Guided PCI in Patients with All-comer STEMI: The ATLAS OCT Trial
(1).jpg)
The ATLAS OCT trial demonstrated that in patients with ST-segment elevation myocardial infarction (STEMI) treated with OCT-guided PCI, both minimum stent area (MSA) and stent expansion index were significant predictors of one-year target vessel failure (TVF; a composite of all-cause death, target vessel myocardial infarction [TV-MI], and target vessel revascularization [TVR]), according to study presented by Dr. Taishi Yonetsu, Tokyo University of Science, Japan, in the Hotline/Late-Breaking Trials session at EuroPCR 2025.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
